A molecularly genetic determination of prognostic factors of the prostate cancer and their relationships to expression of protein p27kip1

Neoplasma

Volumn 54, Issue 2, 2007, Pages 149-154

  Dvorackova, J ^a   Uvirova M ^a  

^a CGB Laborato As   (Czech Republic)

Author keywords

8p22 loss; 8q24 amplification; Gleason's score; Prognosis; Prostate cancer

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; MYC PROTEIN;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CHROMOSOME 8; CHROMOSOME ABERRATION; CLINICAL ARTICLE; GENE AMPLIFICATION; GENE DELETION; GENE FREQUENCY; GENETIC DISORDER; GLEASON SCORE; HEREDITY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MOLECULAR GENETICS; NEEDLE BIOPSY; ONCOGENE C MYC; ONCOGENE MYC; POLYPLOIDY; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR BIOPSY; TUMOR CELL; CHROMOSOME DELETION; ENZYME IMMUNOASSAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; METABOLISM; PATHOLOGY; PROSTATE TUMOR; SURVIVAL RATE;

CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 8; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE AMPLIFICATION; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; PROGNOSIS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; SURVIVAL RATE;

EID: 34347229457     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. KAZUNARI S, QIAN SJ, SLEZAK JM et al.: Clinical significance of alterations of chromosome 8 in high grade, advanced, nonmetastatic prostate carcinoma, Journal of the National Cancer Institute, 1999, 91, 1574-1580.
2. QIAN J, HIRASAWA K. BOSTWICK DG et.al.: Loss of p53 and c-myc overrepresentation in stage T2-3N1-3M0 prostate cancer are potential markers for cancer progression, Modern Patology 2002, 15, 35-44.
3. TSUCHIYA N, SLEZAK JM , LIBER MM, et al.: Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ, confined prostate cancer genes, Chromosomes & Cancer 2002, 34, 363-371. (Pubitemid 34787457)
4. VAN DEKLEM H, ALERS JC, DAMEN IA et al.: Genetic evaluation of localized prostate cancer in a cohort of forty patients: gain of distal 8q discriminates between progressors and nonprogressors, Laboratory Investigation, 2003, 83, 789-796.
5. DVOŘÁČKOVÁ J, ČEGANOVÁ L, ŠTĚRBA J, NEDBÁLEK A, KOLÁŘ Z: "Signs of proliferation and apoptosis in prostatic cancer related to androgen receptor" Československá patologie a soudní lékařství 2006, 3, in print.(in Czech).
6. EBLE NJ, SAUTER G, EPSTEINAND JI et al.: WHO Classification of Tumors, Tumors of the Urinary System and Male Genital Organs , 2004.
7. R Development Core Team (2006). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org.
8. HUGHES S, YOSHIMOTO M, BETHESTHI B et al.: The use of whole genome amplification to study chromosomal changes in prostate cancer: insights into geonome-wide signature of preneoplasie associated with cancer progression, BMC Genomics 2006, 7, 65.
9. ETEM E, ELYAS H, YWCE et al.: Importace of chromosome 8gain and c-myc gene amplification in high grade prostate cancer, F.Ü.Saglik Bil. Dergisi 2004, 18, 157-162.
10. KARASHIMA T, TAGUCHI T, YOSHICAWA C et al.: Numerical chromosomal changes in metastatic prostate cancer following anti-androgen therapy: fluorescence in situ hybridization analysis in Japanese cases. Cancer Genet Cytogenet 2000, 120, 148-154.
11. MATSUYAMA H, PAN Y, OBA K et al.: The role of chromosome 8p22 deletion for predicting disease progression and pathological staging in prostate cancer, Aktuelle Urol.2003, 34: 247-249
12. LI R, WHEELER TM, DAI H et al.: Biological correlates of p27 compartmental expression in prostate cancer, J Urol. 2006, 175, 528-532
13. SHAFFER DR, VIALE A, ISHIWATA R,; LEVERSHA M et al.: Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate. Proc Natl Acad Sci USA 2005; 102: 210-215
14. CLAUDIO PP, ZAMPARELLI A, GARCIA FU et al.: Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma. Clin Cancer Res 2002, 8: 1808-1815
15. DE MARZO AM, MEEKER AK, ZHA S et al.: Human prostate cancer precursors and pathobiology. Urology. 2003; 62(5 Suppl 1): 55-62. (Pubitemid 37371890)
16. DROBNJAK M, MELAMED J, TANEJA S et all.: Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients. Clin Cancer Res 2003, 9: 2613-2619
17. DOGANAVSARGIL B, SIMSIR A, BOYACIOGLU H: A comparison of p21 and p27 immunoexpression in benign glands, prostatic intraepithelial neoplasia and prostate adenocarcinoma, BJU Int. 2006; 97(3): 644-648